Redhill Biopharma LtdRedhill Biopharma Ltd - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

This ESG rating for Redhill Biopharma Ltd represents its reporting of the UN Sustainable Development Goals. Jump to the bottom of this webpage for potential risks for Redhill Biopharma Ltd based on industry, location and size. This webpage displays a free Sustainability assessment for Redhill Biopharma Ltd.

Redhill Biopharma Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.6; made up of an environmental score of 6.4, social score of 4.8 and governance score of 5.3.

SDG Transparency Score for Redhill Biopharma Ltd 
Low
0 - 3

5.6

Medium Impact
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for Redhill Biopharma Ltd 
6.4

Environmental

4.8

Social

5.3

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
774Virpax Pharmaceuticals Inc
5.7
High
774Zymeworks Inc
5.7
High
808Redhill Biopharma Ltd
5.6
High
808Armata Pharmaceuticals Inc
5.6
High
808Biostage Inc
5.6
High
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Redhill Biopharma Ltd have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Redhill Biopharma Ltd disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Redhill Biopharma Ltd report the average age of the workforce?

LockedSign up for free to unlock

Does Redhill Biopharma Ltd reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Redhill Biopharma Ltd disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Redhill Biopharma Ltd disclose cybersecurity risks?

LockedSign up for free to unlock

Does Redhill Biopharma Ltd offer flexible work?

LockedSign up for free to unlock

Does Redhill Biopharma Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Redhill Biopharma Ltd disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Redhill Biopharma Ltd conduct supply chain audits?

LockedSign up for free to unlock

Does Redhill Biopharma Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Redhill Biopharma Ltd conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Redhill Biopharma Ltd disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Redhill Biopharma Ltd disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Redhill Biopharma Ltd disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Redhill Biopharma Ltd disclose water use targets?

LockedSign up for free to unlock

Does Redhill Biopharma Ltd have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Redhill Biopharma Ltd have a product recall in the last two years?

LockedSign up for free to unlock

Does Redhill Biopharma Ltd disclose incidents of discrimination?

LockedSign up for free to unlock

Does Redhill Biopharma Ltd allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Redhill Biopharma Ltd issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Redhill Biopharma Ltd disclose parental leave metrics?

LockedSign up for free to unlock

Does Redhill Biopharma Ltd disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Redhill Biopharma Ltd disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Redhill Biopharma Ltd disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Redhill Biopharma Ltd support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Redhill Biopharma Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Redhill Biopharma Ltd reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Redhill Biopharma Ltd involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Redhill Biopharma Ltd disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Redhill Biopharma Ltd disclose its waste policy?

LockedSign up for free to unlock

Does Redhill Biopharma Ltd report according to TCFD requirements?

LockedSign up for free to unlock

Does Redhill Biopharma Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Redhill Biopharma Ltd disclose energy use targets?

LockedSign up for free to unlock

Does Redhill Biopharma Ltd disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Redhill Biopharma Ltd have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Redhill Biopharma Ltd
These potential risks are based on the size, segment and geographies of the company.

RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for the treatment of travelers' diarrhea in adults. Its clinical late-stage investigational development programs include RHB-204, which is in Phase 3 study for pulmonary nontuberculous mycobacteria infections; opaganib (Yeliva), an SK2 selective inhibitor, which has completed Phase 2 study to treat patients with SARS-CoV-2 severe COVID-19 pneumonia, in Phase 2 study to treat advanced unresectable cholangiocarcinoma, and in investigator-sponsored Phase 2 study to treat prostate cancer; RHB-107, which is in Phase 2/3 study to treat outpatients infected with COVID-19 disease, and preclinical evaluation study to treat advanced unresectable cholangiocarcinoma, as well as has completed Phase 2 study to treat gastrointestinal and other solid tumors; RHB-104, which is in Phase 3 studies for Crohn's disease; RHB-102 (Bekinda) that is in Phase 3 studies for acute gastroenteritis and gastritis, and has completed Phase 2 studies for irritable bowel syndrome with diarrhea; and RHB-106, an encapsulated formulation for bowel preparation, which is preparing for Phase 2/3 study. RedHill Biopharma Ltd. was incorporated in 2009 and is headquartered in Tel Aviv, Israel.

Sorry!

Failed to process!